These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of d-cycloserine on brain processing of breathlessness over pulmonary rehabilitation: an experimental medicine study. Finnegan SL; Harrison OK; Booth S; Dennis A; Ezra M; Harmer CJ; Herigstad M; Guillaume B; Nichols TE; Rahman NM; Reinecke A; Renaud O; Pattinson KTS ERJ Open Res; 2023 Mar; 9(2):. PubMed ID: 37020840 [TBL] [Abstract][Full Text] [Related]
3. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial. Verberkt CA; van den Beuken-van Everdingen MHJ; Schols JMGA; Hameleers N; Wouters EFM; Janssen DJA JAMA Intern Med; 2020 Oct; 180(10):1306-1314. PubMed ID: 32804188 [TBL] [Abstract][Full Text] [Related]
4. Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies. Ferguson GT; Karpel J; Bennett N; Clerisme-Beaty E; Grönke L; Voß F; Buhl R NPJ Prim Care Respir Med; 2017 Feb; 27(1):7. PubMed ID: 28154373 [TBL] [Abstract][Full Text] [Related]
5. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Simon ST; Higginson IJ; Booth S; Harding R; Weingärtner V; Bausewein C Cochrane Database Syst Rev; 2016 Oct; 10(10):CD007354. PubMed ID: 27764523 [TBL] [Abstract][Full Text] [Related]
6. Breathlessness in COPD: linking symptom clusters with brain activity. Finnegan SL; Harrison OK; Harmer CJ; Herigstad M; Rahman NM; Reinecke A; Pattinson KTS Eur Respir J; 2021 Nov; 58(5):. PubMed ID: 33875493 [TBL] [Abstract][Full Text] [Related]
7. Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy. Ekström M; Ahmadi Z; Bornefalk-Hermansson A; Abernethy A; Currow D Cochrane Database Syst Rev; 2016 Nov; 11(11):CD006429. PubMed ID: 27886372 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and management of chronic breathlessness in COPD in a tertiary care center. Carette H; Zysman M; Morelot-Panzini C; Perrin J; Gomez E; Guillaumot A; Burgel PR; Deslee G; Surpas P; Le Rouzic O; Perez T; Chaouat A; Roche N; Chabot F; BMC Pulm Med; 2019 May; 19(1):95. PubMed ID: 31096982 [TBL] [Abstract][Full Text] [Related]
11. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease. Smallwood N; Le B; Currow D; Irving L; Philip J Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary rehabilitation versus usual care for adults with asthma. Osadnik CR; Gleeson C; McDonald VM; Holland AE Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013485. PubMed ID: 35993916 [TBL] [Abstract][Full Text] [Related]
13. Morphine for chronic breathlessness in COPD: improvement predictors-cross-sectional study. Verberkt CA; van den Beuken-Everdingen MHJ; Schols JMGA; Wouters EFM; Janssen DJA BMJ Support Palliat Care; 2024 Jan; 13(e3):e829-e832. PubMed ID: 35850961 [TBL] [Abstract][Full Text] [Related]
14. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD). van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574 [TBL] [Abstract][Full Text] [Related]
15. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Simon ST; Higginson IJ; Booth S; Harding R; Bausewein C Cochrane Database Syst Rev; 2010 Jan; (1):CD007354. PubMed ID: 20091630 [TBL] [Abstract][Full Text] [Related]
16. Comparison of respiratory health-related quality of life in patients with intractable breathlessness due to advanced cancer or advanced COPD. Javadzadeh S; Chowienczyk S; Booth S; Farquhar M BMJ Support Palliat Care; 2016 Mar; 6(1):105-8. PubMed ID: 26685116 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care. Müllerová H; Lu C; Li H; Tabberer M PLoS One; 2014; 9(1):e85540. PubMed ID: 24427316 [TBL] [Abstract][Full Text] [Related]
18. Building consensus for provision of breathlessness rehabilitation for patients with chronic obstructive pulmonary disease and chronic heart failure. Man WD; Chowdhury F; Taylor RS; Evans RA; Doherty P; Singh SJ; Booth S; Thomason D; Andrews D; Lee C; Hanna J; Morgan MD; Bell D; Cowie MR Chron Respir Dis; 2016 Aug; 13(3):229-39. PubMed ID: 27072018 [TBL] [Abstract][Full Text] [Related]
19. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Barnes H; McDonald J; Smallwood N; Manser R Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011008. PubMed ID: 27030166 [TBL] [Abstract][Full Text] [Related]
20. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ekström M; Nilsson F; Abernethy AA; Currow DC Ann Am Thorac Soc; 2015 Jul; 12(7):1079-92. PubMed ID: 25803110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]